A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness
Advanced Science · 2026
DOI: 10.1002/advs.202511780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Naji L N Alnagger und 17 weiteren Autor:innen. Beteiligte Einrichtung: Coma Science Group, GIGA-Consciousness, University of Liège, Avenue de l'hôpital 11, Liège, 4000, Belgium. Hauptthemen laut MEDLINE: Hallucinogens, Consciousness Disorders, Lysergic Acid Diethylamide, Psilocybin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University and University Hospital of Liege, The ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), FLAG-ERA JTC2023 project BrainAct.
Abstract (Originalsprache)
Disorders of consciousness (DoC), including unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), have limited treatment options and are characterized by low complexity of brain activity. Recent research suggests that psychedelic drugs, which enhance the complexity of brain activity, could offer promising therapies. Here, individualized whole‐brain computational models are developed for patients with DoC, optimized with empirical functional magnetic resonance imaging data and diffusion‐weighted imaging data, upon which the administration of lysergic acid diethylamide (LSD) and psilocybin is simulated. An in silico perturbation protocol is applied to assess brain dynamics, first distinguishing between different states of consciousness, including DoC, anesthesia, and the psychedelic state. Then, brain dynamics are assessed before and after a simulation of psychedelic drugs on patients with DoC. Findings indicated that the simulation of LSD and psilocybin shifted the brain activity of patients with DoC closer to criticality (the point at a phase transition between order and chaos), with a greater effect in patients in the MCS. In patients with UWS, the treatment response correlated with structural connectivity, while in patients in the MCS, it aligned with baseline functional connectivity. These results offer a computational foundation for using psychedelics in DoC treatment and highlight the potential future role of computational modeling in drug discovery and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Coma Science Group, GIGA-Consciousness, University of Liège, Avenue de l'hôpital 11, Liège, 4000, Belgium.
- NeuroRehab & Consciousness Clinic, Neurology Department, University Hospital of Liège, Avenue de l'hôpital 11, Liège, 4000, Belgium.
- Institut du Cerveau - Paris Brain Institute - ICM, Inserm CNRS, Sorbonne Université, Paris, 75013, France.
- Department of Information and Communication Technologies, Centre for Brain and Cognition, Computational Neuroscience Group, Universitat Pompeu Fabra, Barcelona, 08005, Spain.
- Department of Psychology, University of Exeter, Exeter, EX4 4QG, UK.
- Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, W12 0HS, UK.
ORCID-Profile: Naji L N Alnagger, Paolo Cardone, Charlotte Martial, Yonatan Sanz Perl, Iván Mindlin, Jacobo D Sitt, Leor Roseman, Robin Carhart-Harris, David Nutt, Pablo Mallaroni, Natasha Mason, Johannes G Ramaekers, Steven Laureys, Gustavo Deco, Olivia Gosseries, Pablo Núñez, Jitka Annen
Förderung
- University and University Hospital of Liege
- The ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project)
- FLAG-ERA JTC2023 project BrainAct
- Fonds De La Recherche Scientifique - FNRS
Zitieren
APA
Alnagger, N. L. N., Cardone, P., Martial, C., Perl, Y. S., Mindlin, I., Sitt, J. D., Roseman, L., Carhart-Harris, R., Nutt, D., Mallaroni, P., Mason, N., Ramaekers, J. G., Bonhomme, V., Laureys, S., Deco, G., Gosseries, O., Núñez, P., & Annen, J. (2026). A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness. Advanced Science. https://doi.org/10.1002/advs.202511780
Vancouver
Alnagger NLN, Cardone P, Martial C, Perl YS, Mindlin I, Sitt JD, et al. A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness. Advanced Science. 2026. doi:10.1002/advs.202511780
BibTeX
@article{Alnagger2026,
author = {Alnagger, Naji L N and Cardone, Paolo and Martial, Charlotte and Perl, Yonatan Sanz and Mindlin, Iván and Sitt, Jacobo D and Roseman, Leor and Carhart-Harris, Robin and Nutt, David and Mallaroni, Pablo and Mason, Natasha and Ramaekers, Johannes G and Bonhomme, Vincent and Laureys, Steven and Deco, Gustavo and Gosseries, Olivia and Núñez, Pablo and Annen, Jitka},
title = {A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202511780}
}
EUVIMED